Practical Geriatrics ›› 2026, Vol. 40 ›› Issue (10): 997-1005.doi: 10.3969/j.issn.1003-9198.2026.10.005
Previous Articles Next Articles
WEI Liqin, QIN Li, LI Guochao, ZHUANG Mengping, ZHANG Yumin, LIU Juan
Received:2026-05-01
Published:2026-10-23
Contact:
LIU Juan, Email: lioujane@njmu.edu.cn
CLC Number:
WEI Liqin, QIN Li, LI Guochao, ZHUANG Mengping, ZHANG Yumin, LIU Juan. Mechanism of 11β-HSD1 inhibition in alleviating palmitic acid-induced reactive astrocyte activation[J]. Practical Geriatrics, 2026, 40(10): 997-1005.
| [1] UCHIDA K, SUGIMOTO T, TANGE C, et al. Association between abdominal adiposity and cognitive decline in older adults: a 10-year community-based study[J]. J Nutr Health Aging, 2024, 28(3): 100175. [2] WEST N A, LIRETTE S T, CANNON V A, et al. Adiposity, change in adiposity, and cognitive decline in mid-and late life[J]. J Am Geriatr Soc, 2017, 65(6):1282-1288. [3] ZENG J, CHEONG L Y T, LO C H. Therapeutic targeting of obesity-induced neuroinflammation and neurodegeneration[J]. Front Endocrinol, 2025, 15: 1456948. [4] DIDIĆ-KRIVIĆ A, FAJKIĆ A, FARHAT E K, et al. Linking metabolic syndrome to neurodegeneration mechanisms and potential treatments[J]. Mol Neurobiol, 2025, 62(11): 14344-14366. [5] SCHMITT L O, BLANCO A, LIMA S V, et al. Palmitate compromises C6 astrocytic cell viability and mitochondrial function[J]. Metabolites, 2024, 14(3): 161. [6] SOFRONIEW M V, VINTERS H V. Astrocytes: biology and pathology[J]. Acta Neuropathol, 2010, 119(1): 7-35. [7] ORTEGA A, MARTÍNEZ-NUNCIO L A, TADDEI E, et al. ASTROGLIA: molecular mechanisms, functional roles, and neurophysiological implications in the central nervous system[J]. Life: Basel, 2025, 15(10): 1505. [8] SIVASUBRAMANIAN M K, MONTEIRO R, JAGADEESH M, et al. Palmitic acid induces oxidative stress and senescence in human brainstem astrocytes, downregulating glutamate reuptake transporters-implications for obesity-related sympathoexcitation[J]. Nutrients, 2024, 16(17):2852. [9] GUPTA S, KNIGHT A G, GUPTA S, et al. Saturated long-chain fatty acids activate inflammatory signaling in astrocytes[J]. J Neurochem, 2012, 120(6):1060-1071. [10] PERTICHETTI M, SERIOLI S, BELOTTI F, et al. Pituitary adenomas and neuropsychological status: a systematic literature review[J]. Neurosurg Rev, 2020, 43(4): 1065-1078. [11] HENRY M, THOMAS K G F, ROSS I L. Episodic memory impairment in Addison’s disease: results from a telephonic cognitive assessment[J]. Metab Brain Dis, 2014, 29(2): 421-430. [12] SECKL J. 11β-Hydroxysteroid dehydrogenase and the brain: not(yet) lost in translation[J]. J Intern Med, 2024, 295(1):20-37. [13] SECKL J R, WALKER B R. 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory[J]. Trends Endocrinol Metab, 2004, 15(9):418-424. [14] PARK B, CHOI G E. Changes in astrocyte function induced by stress-induced glucocorticoid exacerbate major depressive disorder[J]. Prog Neurobiol, 2025, 251:102786. [15] LIU J, WANG L, ZHANG A, et al. Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity[J]. Endocr J, 2011, 58(3): 199-209. [16] 曹清, 秦丽 , 刘娟. 11β-羟化类固醇脱氢酶敲除对高脂饮食喂养小鼠认知功能的影响[J]. 南京医科大学学报(自然科学版), 2023, 43(8):1047-1054. [17] PUIGORIOL-ILLAMOLA D, LEIVA R, VÁZQUEZ-CARRERA M, et al. 11β-HSD1 inhibition rescues SAMP8 cognitive impairment induced by metabolic stress[J]. Mol Neurobiol, 2020, 57(1): 551-565. [18] SOFRONIEW M V. Astrocyte reactivity: subtypes, states, and functions in CNS innate immunity[J]. Trends Immunol, 2020, 41(9): 758-770. [19] CAMERON E G, NAHMOU M, TOTH A B, et al. A molecular switch for neuroprotective astrocyte reactivity[J]. Nature, 2024, 626(7999): 574-582. [20] WANG L, LIU J, ZHANG A, et al. BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice[J]. PLoS One, 2012, 7(7): e40056. [21] ZHANG Z, YIN B, ZHU D, et al. 11β-HSD1 inhibitor alleviates sepsis-induced cardiac dysfunction by regulating macrophage polarization via the AMPK/mTOR autophagy pathway[J]. J Cardiol, 2026, 87(6): 536-549. [22] 尹立平, 王龙, 吕珊, 等. 11β-HSD1抑制剂BVT.2733对肥胖小鼠多器官组织代谢与炎症相关基因表达的影响[J]. 南京医科大学学报(自然科学版), 2019, 39(12):1716-1722. [23] MATHYS H, BOIX C A, AKAY L A, et al. Single-cell multiregion dissection of Alzheimer’s disease[J]. Nature, 2024, 632(8026): 858-868. [24] ORTIZ-RODRIGUEZ A, ACAZ-FONSECA E, BOYA P, et al. Lipotoxic effects of palmitic acid on astrocytes are associated with autophagy impairment[J]. Mol Neurobiol, 2019, 56(3):1665-1680. [25] LAHIRI A, SIMS S G, HERSTINE J A, et al. Endoplasmic reticulum stress amplifies cytokine responses in astrocytes via a PERK/eIF2α/JAK1 signaling axis[J]. Glia, 2025, 73(11): 2273-2288. [26] MATIENZO M E, LEE J, LIM S, et al. Adipocyte-specific modulation of 11β-HSD enzymes for the treatment of obesity in male mice[J]. Am J Physiol Cell Physiol, 2025, 329(2): C530-C539. [27] DI VINCENZO M, PELLEGRINO P, SCHIAPPA G, et al. Role of 11β-hydroxysteroid dehydrogenase and mineralocorticoid receptor on Alzheimer’s disease onset: a systematic review[J]. Int J Mol Sci, 2025, 26(3):1357. [28] HEIN T M, NESPOLI E, HAKANI M, et al. NF-κB activation in astrocytes impairs wound healing after traumatic brain injury in male mice[J]. Nat Commun, 2026, 17(1): 2323. [29] CHI G, LU J, HE T, et al. High mobility group box-1 protein promotes astrocytic CCL5 production through the MAPK/NF-κB pathway following spinal cord injury[J]. Sci Rep, 2024, 14(1): 22344. [30] CHEN L, ZHAO X, SHENG R, et al. Artemisinin alleviates astrocyte overactivation and neuroinflammation by modulating the IRE1/NF-κB signaling pathway in in vitro and in vivo Alzheimer’s disease models[J]. Free Radic Biol Med, 2025, 229: 96-110. |
| [1] | LI Yangbo, ZHAO Zhengkun. Predictive value of residual cholesterol inflammation index for the prognosis in elderly patients with unstable angina pectoris [J]. Practical Geriatrics, 2026, 40(8): 811-815. |
| [2] | ZHOU Tingfan, HUANG Tianwen. Advances in immunotherapy for Alzheimer’s disease [J]. Practical Geriatrics, 2026, 40(5): 445-450. |
| [3] | LIU Yukun, LEI Jiawei, ZHU Chunming, ZHANG Yuqiang, WANG Jiahe. Research progress on molecular mechanism and drug target of fraity syndrome [J]. Practical Geriatrics, 2026, 40(3): 224-228. |
| [4] | JIN Jingjing, GU Qiuli, LEI Jaiwei, WANG Jiahe. Research progress on drug targets for age-related hearing loss [J]. Practical Geriatrics, 2026, 40(2): 111-115. |
| [5] | CHENG Yi, ZOU Ting, LI Lihua, ZHANG Lei, ZHOU Xiaohui. Study on the mechanism of lncRNA AL133415.1 in regulating vimentin gene expression in SH-SY5Y cells [J]. Practical Geriatrics, 2026, 40(2): 126-131. |
| [6] | YAN Su, WANG Zewen, CHEN Yilan, CHEN Rui, DING Siyu, TANG Zhongquan, OU Ting. Research progress on the shared pathogenesis of frailty and cardiometabolic multimorbidity [J]. Practical Geriatrics, 2026, 40(10): 1038-1042. |
| [7] | DUAN Jingyi, MA Yanan, Aeryoubu, FENG Shuqi, YUAN Hui, LIAO Xichu, GAO Haiying. Association of inflammation and frailty [J]. Practical Geriatrics, 2025, 39(7): 649-653. |
| [8] | YI Xinmei, ZHANG Fei, WANG Jiahe. Research progress on the association between inflammation and sarcopenia in the elderly [J]. Practical Geriatrics, 2025, 39(7): 654-658. |
| [9] | ZHOU Chong, LIU Zuwang, ZHANG Fei, WANG Jiahe. Research progress on the relationship between inflammation and chronic pain [J]. Practical Geriatrics, 2025, 39(7): 659-662. |
| [10] | WANG Qi, WANG Zhe, WANG Yuehui. Research progress on inflammation and sleep disorders [J]. Practical Geriatrics, 2025, 39(6): 543-546. |
| [11] | CHANG Lin, GAO Yonghong. Research progress of inflammation and cognitive impairment [J]. Practical Geriatrics, 2025, 39(6): 547-550. |
| [12] | DENG Chaowei, LIU Danli, YE Xujun. Inflammation and common geriatric syndromes: research progress with a focus on hearing impairment [J]. Practical Geriatrics, 2025, 39(6): 551-554. |
| [13] | AN Fangjie, LIU Ying, ZHAO He. Relationship between pan-immune-inflammation index and the severity of diabetic retinopathy with macular edema in elderly patients [J]. Practical Geriatrics, 2025, 39(4): 387-390. |
| [14] | WANG Yan, XU Jie, GU Xiaoping. Research advances on association between fatty acid metabolism and Alzheimer’s disease [J]. Practical Geriatrics, 2025, 39(4): 415-419. |
| [15] | LIN Xiaoqi, ZHAO Xinjing, WU Yashuang, ZHAO Wei, CHEN Chen, GAO Tianyu, ZHOU Guoyu. Advances of the mechanisms of gender differences in Alzheimer’s disease [J]. Practical Geriatrics, 2025, 39(4): 420-425. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|